These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18560012)

  • 1. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.
    Miller DS; Bauer B; Hartz AM
    Pharmacol Rev; 2008 Jun; 60(2):196-209. PubMed ID: 18560012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier.
    Bauer B; Hartz AM; Miller DS
    Mol Pharmacol; 2007 Mar; 71(3):667-75. PubMed ID: 17132686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide.
    Hartz AM; Bauer B; Fricker G; Miller DS
    Mol Pharmacol; 2006 Feb; 69(2):462-70. PubMed ID: 16278373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.
    Rigor RR; Hawkins BT; Miller DS
    J Cereb Blood Flow Metab; 2010 Jul; 30(7):1373-83. PubMed ID: 20197783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
    Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
    Cartwright TA; Campos CR; Cannon RE; Miller DS
    J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.
    Demeule M; Régina A; Jodoin J; Laplante A; Dagenais C; Berthelet F; Moghrabi A; Béliveau R
    Vascul Pharmacol; 2002 Jun; 38(6):339-48. PubMed ID: 12529928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
    Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
    Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of p-glycoprotein transport function at the blood-brain barrier.
    Bauer B; Hartz AM; Fricker G; Miller DS
    Exp Biol Med (Maywood); 2005 Feb; 230(2):118-27. PubMed ID: 15673560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier.
    Soldner ELB; Hartz AMS; Akanuma SI; Pekcec A; Doods H; Kryscio RJ; Hosoya KI; Bauer B
    FASEB J; 2019 Dec; 33(12):13966-13981. PubMed ID: 31638830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.
    Miller DS
    Trends Pharmacol Sci; 2010 Jun; 31(6):246-54. PubMed ID: 20417575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier.
    Hartz AM; Bauer B; Block ML; Hong JS; Miller DS
    FASEB J; 2008 Aug; 22(8):2723-33. PubMed ID: 18474546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
    Miller DS
    Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia.
    Ding Y; Wang R; Zhang J; Zhao A; Lu H; Li W; Wang C; Yuan X
    Curr Pharm Des; 2019; 25(10):1041-1051. PubMed ID: 31187705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation.
    Bauer B; Yang X; Hartz AM; Olson ER; Zhao R; Kalvass JC; Pollack GM; Miller DS
    Mol Pharmacol; 2006 Oct; 70(4):1212-9. PubMed ID: 16837625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier.
    Pathan N; Shende P
    J Control Release; 2021 Jul; 335():398-407. PubMed ID: 34087246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein.
    Dolghih E; Jacobson MP
    ACS Chem Neurosci; 2013 Feb; 4(2):361-7. PubMed ID: 23421687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.
    Banks DB; Chan GN; Evans RA; Miller DS; Cannon RE
    J Cereb Blood Flow Metab; 2018 May; 38(5):857-868. PubMed ID: 28447863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.
    Potschka H
    Pharmacol Ther; 2010 Jan; 125(1):118-27. PubMed ID: 19896502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.